Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T06569 | Target Info | |||
Target Name | Carbonic anhydrase VI (CA-VI) | ||||
Synonyms |
Secreted carbonic anhydrase; Salivary carbonic anhydrase; Carbonic anhydrase 6; Carbonate dehydratase VI
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | CA6 | ||||
Biochemical Class | Alpha-carbonic anhydrase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Carbonic anhydrase XII (CA-XII) | Successful Target | ||||
UniProt ID | CAH12_HUMAN | |||||
Gene Name | CA12 | |||||
Synonyms |
Tumor antigen HOM-RCC-3.1.3; Carbonic anhydrase 12; Carbonate dehydratase XII
Click to Show/Hide
|
|||||
Representative Drug(s) | Sulfamylon | Drug Info | Ki = 0.3 nM | [1] | ||
Co-Target Name | Steryl-sulfatase (STS) | Successful Target | ||||
UniProt ID | STS_HUMAN | |||||
Gene Name | STS | |||||
Synonyms |
Steryl-sulfate sulfohydrolase; Steroid sulfatase; STS; Estrone sulfatase; Arylsulfatase C; ASC
Click to Show/Hide
|
|||||
Representative Drug(s) | Coumate | Drug Info | IC50 = 10 uM tube-1 | [2] | ||
Co-Target Name | Carbonic anhydrase II (CA-II) | Successful Target | ||||
UniProt ID | CAH2_HUMAN | |||||
Gene Name | CA2 | |||||
Synonyms |
Carbonic anhydrase C; Carbonic anhydrase 2; Carbonate dehydratase II; CAC
Click to Show/Hide
|
|||||
Representative Drug(s) | Coumate | Drug Info | Ki = 25 nM | Click to Show More | [3] | |
2 | Sulfamylon | Drug Info | Ki = 170 nM | [4] | ||
Co-Target Name | Amyloid beta A4 protein (APP) | Successful Target | ||||
UniProt ID | A4_HUMAN | |||||
Gene Name | APP | |||||
Synonyms |
Protease nexin-II; PreA4; PN-II; Cerebral vascular amyloid peptide; CVAP; Amyloid-beta precursor protein; Amyloid-beta A4 protein; Alzheimer disease amyloid protein; APPI; APP; AD1; ABPP; A4
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | IC50 = 630 nM | [5] | ||
Co-Target Name | Monoamine oxidase type A (MAO-A) | Successful Target | ||||
UniProt ID | AOFA_HUMAN | |||||
Gene Name | MAOA | |||||
Synonyms |
Monoamine oxidase A; Amine oxidase [flavin-containing] A
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | Ki = 710 nM | [6] | ||
Co-Target Name | Lactoylglutathione lyase (GLO1) | Clinical trial Target | ||||
UniProt ID | LGUL_HUMAN | |||||
Gene Name | GLO1 | |||||
Synonyms |
S-D-lactoylglutathione methylglyoxal lyase; Methylglyoxalase; Ketone-aldehyde mutase; Glyoxalase I; GlxI; Glx I; GLO1; Aldoketomutase
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | Ki = 5 nM | [7] | ||
Co-Target Name | Tissue factor (F3) | Successful Target | ||||
UniProt ID | TF_HUMAN | |||||
Gene Name | F3 | |||||
Synonyms |
Thromboplastin; TF; F3; Coagulation factor III; CD142 antigen
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | IC50 = 13.16 nM | [8] | ||
Co-Target Name | Carbonic anhydrase IX (CA-IX) | Clinical trial Target | ||||
UniProt ID | CAH9_HUMAN | |||||
Gene Name | CA9 | |||||
Synonyms |
Renal cell carcinoma-associated antigen G250; RCC-associated antigen G250; PMW1; P54/58N; Membrane antigen MN; MN; G250 antigen (MN/CA IX/G250); G250; Carbonic anhydrase 9; Carbonate dehydratase IX; CAIX
Click to Show/Hide
|
|||||
Representative Drug(s) | Sulfamylon | Drug Info | Ki = 103 nM | [9] | ||
Co-Target Name | Prostaglandin E synthase (PTGES) | Clinical trial Target | ||||
UniProt ID | PTGES_HUMAN | |||||
Gene Name | PTGES | |||||
Synonyms |
p53-induced gene 12 protein; PIG12; PGES; PGE synthase; P53-induced apoptosis protein 12; Microsomal prostaglandin E synthase 1; Microsomal glutathione S-transferase 1-like 1; MPGES1; MPGES-1; MGST1L1; MGST1-L1
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | IC50 = 200 nM | [10] | ||
Co-Target Name | Carbonic anhydrase VII (CA-VII) | Patented-recorded Target | ||||
UniProt ID | CAH7_HUMAN | |||||
Gene Name | CA7 | |||||
Synonyms |
Carbonic anhydrase 7; Carbonate dehydratase VII
Click to Show/Hide
|
|||||
Representative Drug(s) | Sulfamylon | Drug Info | Ki = 75 nM | [11] | ||
Co-Target Name | Nicotinate phosphoribosyltransferase (NAPRT) | Co-Target | ||||
UniProt ID | PNCB_HUMAN | |||||
Gene Name | NAPRT | |||||
Synonyms |
NAPRTase; FHA-HIT-interacting protein; Nicotinate phosphoribosyltransferase domain-containing protein 1
Click to Show/Hide
|
|||||
Representative Drug(s) | Salicyclic acid | Drug Info | Ki = 0.16 nM | [12] | ||
Co-Target Name | CDGSH iron-sulfur domain-containing protein 1 (CISD1_HUMAN) | Co-Target | ||||
UniProt ID | CISD1_HUMAN | |||||
Gene Name | CISD1 | |||||
Synonyms |
MitoNEET
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | Ki = 101 nM | [13] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglauc... Bioorg Med Chem Lett. 2005 Feb 15;15(4):963-9. | ||||
REF 2 | Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES). Bioorg Med Chem Lett. 2002 May 20;12(10):1343-6. | ||||
REF 3 | Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5192-6. | ||||
REF 4 | Carbonic anhydrase inhibitors: synthesis of N-morpholylthiocarbonylsulfenylamino aromatic/heterocyclic sulfonamides and their interaction with isozymes I, II and IV. Bioorg Med Chem Lett. 2000 May 15;10(10):1117-20. | ||||
REF 5 | Neuritogenic activity of bi-functional bis-tryptoline triazole. Bioorg Med Chem. 2017 Feb 1;25(3):1195-1201. | ||||
REF 6 | Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis. ACS Med Chem Lett. 2015 Dec 1;7(1):56-61. | ||||
REF 7 | Recent advances in the discovery and development of glyoxalase I inhibitors. Bioorg Med Chem. 2020 Feb 15;28(4):115243. | ||||
REF 8 | Microbial hydroxylation and glycosylation of pentacyclic triterpenes as inhibitors on tissue factor procoagulant activity. Bioorg Med Chem Lett. 2017 Feb 15;27(4):1026-30. | ||||
REF 9 | Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases. J Med Chem. 2010 Apr 8;53(7):2913-26. | ||||
REF 10 | Targeting microsomal prostaglandin E2 synthase-1 (mPGES-1): the development of inhibitors as an alternative to non-steroidal anti-inflammatory drugs (NSAIDs). Medchemcomm. 2015;6:2081-123. | ||||
REF 11 | Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett. 2005 Feb 15;15(4):971-6. | ||||
REF 12 | WHO patent application no. 2017162840A1, SENSITIZATION OF CANCER CELLS TO NAMPT INHIBITORS BY NICOTINIC ACID PHOSPHORIBOSYLTRANSFERASE NEUTRALIZATION. | ||||
REF 13 | Identification of small molecules that bind to the mitochondrial protein mitoNEET. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5350-5353. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.